Krankenhaus der Barmherzigen Brüder Trier

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · The Lancet Oncology · 2009 · 953 citations

Hepatology, Gastrointestinal Oncology, Medicine +8

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

Jacob M. van Laar, Dominique Farge, Jacob K. Sont et al. · JAMA · 2014 · 725 citations · Full text

Transcatheter aortic valve implantation: first results from a multi-centre real-world registry

Ralf Zahn, Ulrich Gerckens, E. Grube et al. · European Heart Journal · 2010 · 596 citations · Full text

Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation

Peter Sick, Gerhard Schüler, Karl Eugen Hauptmann et al. · Journal of the American College of Cardiology · 2007 · 353 citations

Thrombosis, Electrophysiological Evaluation, Device Therapy +14

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · Annals of Oncology · 2014 · 258 citations · Full text

Surgical Oncology, Hepatology, Gastrointestinal Oncology +10